USPTO Examiner PHILIPS BRADLEY H - Art Unit 3799

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18929508METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOFOctober 2024October 2025Allow1221NoNo
18567851SANITARY ARTICLE COMPRISING SHAPING ELEMENTSDecember 2023September 2024Allow1010NoNo
18487172ABSORBENT ARTICLE WITH FUNCTION-FORMED TOPSHEET, AND METHOD FOR MANUFACTURINGOctober 2023April 2025Allow1810NoNo
18327448HEADGEAR, INTERFACE AND AN ASSEMBLYJune 2023December 2025Abandon3010NoNo
18250683ASSEMBLY FOR DIVERTING LIQUID FROM A RESPIRATORY DEVICEApril 2023March 2026Allow3400YesNo
18134644CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICEApril 2023February 2026Allow3400YesNo
18006256VIBRATION DECOUPLERJanuary 2023January 2026Allow3610YesNo
18009906FACE MASK HAVING IMPROVED AIR PERMEABILITYDecember 2022December 2025Allow3610YesNo
18079334NASAL ADMINISTRATIONDecember 2022January 2026Allow3710NoNo
18078565ENDOTRACHEAL TUBEDecember 2022March 2026Abandon3910NoNo
18078196PATIENT INTERFACEDecember 2022October 2025Allow3500NoNo
18062753Drive MechanismDecember 2022February 2026Allow3810YesNo
18061670Portable Vaporizer Device with Multiple Cartridge CapabilityDecember 2022March 2026Allow3910NoNo
17927228RESPIRATOR MASKNovember 2022February 2026Abandon3910NoNo
17927133RESPIRATOR MASKNovember 2022March 2026Abandon4010NoNo
17922773SYSTEM AND METHOD FOR GENERATING PATIENT-SPECIFIC VENTILATION SETTINGS BASED ON LUNG MODELINGNovember 2022November 2025Allow3710YesNo
17972221NON-INVASIVE BREATHING ASSISTANCE APPARATUS AND METHODOctober 2022July 2025Allow3310YesNo
17917797ARTICLE FOR INFECTION PREVENTION FOR FOMITE MATERIALSOctober 2022March 2026Abandon4101NoNo
17917436ABSORBENT COMPOSITES CONTAINING EMBOSSED SUPERABSORBENT MATERIALSOctober 2022August 2023Allow1110YesNo
17949513RAPID-TESTING MASKSeptember 2022January 2026Abandon4010NoNo
17948494Face Aerogel Cover EquipmentSeptember 2022March 2026Allow4211NoNo
17944304WEARABLE SUPPORT DEVICESeptember 2022November 2025Allow3810NoNo
17910771IMPROVED FILTERING MASKSeptember 2022March 2026Abandon4201NoNo
17903153SANITIZING FACE MASKSeptember 2022January 2026Abandon4110NoNo
17797417PRESSURISED DISPENSING CONTAINERAugust 2022September 2025Allow3810NoNo
17877709ENDOTRACHEAL TUBE APPARATUS AND METHODSJuly 2022December 2025Allow4121YesNo
17815212Head Covering Device Providing Filtered AirJuly 2022May 2025Allow3400NoNo
17815210Balanced Device Providing Filtered Air for a UserJuly 2022November 2025Allow3910NoNo
17868189ABSORBENT ARTICLE HAVING A FASTENING SYSTEM WITH A VISUAL CUEJuly 2022March 2025Allow3220YesNo
17792689New Nasal Respiratory ApparatusJuly 2022October 2025Allow4010YesNo
17849572Mask for Detecting Virus of Respiratory Tract InfectionJune 2022May 2025Allow3500YesNo
17846206ARRANGEMENTS FOR HEADGEAR STRAP MANAGEMENTJune 2022December 2025Allow4211YesNo
17808150NASAL CANNULAJune 2022March 2026Abandon4520NoNo
17837007MASK CAPABLE OF BLOCKING AIR FLOWS BETWEEN MOUTH AND NOSEJune 2022December 2025Abandon4210NoNo
17824292Face Mask With Releasable Lower Portion To Enable Eating And DrinkingMay 2022December 2025Abandon4810NoNo
17654741System and Method for Automated Titration of Continuous Positive Airway Pressure Using an Obstruction IndexMarch 2022September 2024Allow3100NoNo
17651044METERED DOSE INHALERS OF FLUTICASONE OR AN ESTER THEREOFFebruary 2022October 2025Allow4420NoNo
17581242Article of Apparel with Breathable Face CoveringJanuary 2022February 2026Allow4821YesNo
17648377MEDICAL VENTILATOR HAVING IN-SERIES PISTON PUMPSJanuary 2022November 2025Abandon4610NoNo
17573684PERSONAL RESPIRATORY PROTECTION DEVICEJanuary 2022March 2025Allow3800NoNo
17566878Breathable Face MaskDecember 2021July 2025Allow4210NoNo
17623522SEAL-FORMING STRUCTURE FOR PATIENT INTERFACE INCLUDING TEXTILE SEAL MEMBERDecember 2021July 2025Allow4310YesNo
17553345Protective shield for odontological proceduresDecember 2021August 2025Abandon4410NoNo
17643041SYSTEM AND METHOD FOR CONTEXT AWARE NETWORKED MASK WITH DYNAMIC AIR IMPEDANCE FOR OPTIMUM BREATHABILITYDecember 2021August 2025Allow4510YesNo
17530129FILTER CARTRIDGE HOLDER WITH FIT-CHECK DEVICENovember 2021July 2025Allow4321YesYes
17512529DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERYOctober 2021June 2025Allow4311NoNo
17509279SANITIZING FACE MASKOctober 2021March 2025Allow4010NoNo
17482299PARTICLE RETAINER DEVICE AND METHODSeptember 2021June 2025Abandon4520NoNo
17428430MONOLITHIC MICROFABRICATED VIBRATING MESH ATOMIZERAugust 2021March 2026Allow5540YesNo
17357824SINGLE DOSE INHALER MONITORING ATTACHMENTJune 2021May 2025Allow4720YesNo
17357021HUMIDIFIERJune 2021January 2025Allow4210YesNo
17353273VALSALVA MASKJune 2021July 2025Allow4811YesNo
17293140DISPOSABLE HYGIENE ARTICLE WITH IMPROVED FITMay 2021April 2022Allow1110NoNo
17317373SECURE LIQUID CONSUMPTION FACE COVERINGMay 2021May 2022Allow1221YesNo
17240242Disposable Absorbent Pants With Advantageous Stretch And Manufacturability Features, And Methods For Manufacturing The SameApril 2021October 2025Allow5331YesNo
17190468HIP-TO-WAIST SILHOUETTES OF ADULT DISPOSABLE ABSORBENT ARTICLES AND ARRAYSMarch 2021December 2024Allow4510NoNo
17151848ABSORBENT ARTICLEJanuary 2021March 2025Abandon5010NoNo
17092131ELASTIC, NONWOVEN FACE COVERINGS AND PACKAGES CONTAINING FACE COVERINGSNovember 2020July 2022Abandon2031YesNo
17087866Breathable Face MaskNovember 2020May 2021Allow610YesNo
17027809AIR DELIVERY CONDUITSeptember 2020July 2024Allow4500NoNo
16762689ABSORBENT ARTICLE AND METHOD FOR MANUFACTURING ABSORBENT ARTICLEMay 2020January 2021Allow910YesNo
16758513ABSORBENT ASSEMBLIES AND ABSORBENT ARTICLES INCLUDING A HYDROPHOBICALLY MODIFIED POLYMERApril 2020June 2021Allow1411NoNo
16829876VALSALVA MASKMarch 2020March 2021Allow1200YesNo
16794882ABSORBENT ARTICLE WITH WAISTBANDFebruary 2020November 2024Abandon5720NoNo
16779970CLOSURE SYSTEM FOR A DRAINABLE POUCHFebruary 2020May 2024Allow5210NoNo
16774395HALF FACEPIECEJanuary 2020July 2025Abandon6021NoNo
16751228ABSORBENT ARTICLES HAVING A BELT PORTION WITH A TEXTURE ZONE HAVING A TEXTURE RATIOJanuary 2020April 2025Allow6031NoNo
16751358ABSORBENT ARTICLES HAVING TEXTURED ZONESJanuary 2020February 2026Allow6051NoNo
16751613DISPOSABLE ABSORBENT ARTICLESJanuary 2020March 2025Abandon6020NoNo
16629268ABSORBENT ARTICLEJanuary 2020March 2025Abandon6020NoNo
16625197FOLDED INDIVIDUAL ARTICLE IN A CIRCULAR PACKAGEDecember 2019September 2023Allow4500NoNo
16625541CONNECTORS FOR RESPIRATORY ASSISTANCE SYSTEMSDecember 2019January 2024Allow4850YesNo
16625175FOLDED INDIVIDUAL ARTICLE IN A CIRCULAR PACKAGEDecember 2019June 2023Allow4200NoNo
16711808ABSORBENT ARTICLE HAVING A MULTI-COMPONENT VISUAL SIGNALDecember 2019February 2025Allow6030YesNo
16697848Rebreathing Apparatus Having Inhaled Oxygen Mixing And Exhaled Carbon Dioxide Removal Functions By Electronic ControlNovember 2019April 2023Allow4120NoNo
16695900ABSORBENT ARTICLE WITH WAISTBANDNovember 2019August 2024Abandon5710NoNo
16694837FLUID COMMUNICATION PATHNovember 2019June 2025Allow6031YesNo
16694017DELIVERY SYSTEMNovember 2019December 2024Allow6010NoNo
16658246ABSORBENT ARTICLES WITH CHANNELS AND/OR POCKETSOctober 2019October 2025Abandon6041YesNo
16656739TUB FOR HUMIDIFIEROctober 2019February 2024Allow5200NoNo
16605233REPLACEABLE FLOW TRACT FOR AN INHALEROctober 2019August 2024Allow5811NoNo
16598188Blind intubation device and related methodologies for endotracheal intubationOctober 2019January 2024Abandon5210NoNo
16597320ABSORBENT ARTICLE WITH SELECTIVELY POSITIONED WAIST CONTAINMENT MEMBER HAVING AN IMPROVED WAIST SEALOctober 2019February 2024Allow5220NoNo
16492726ABSORBENT BODY AND ABSORBENT ARTICLE COMPRISING THE SAMESeptember 2019June 2023Allow4500NoNo
16564085ABSORBENT ARTICLES WITH UNIFORM GRAPHICSSeptember 2019August 2024Abandon5920NoNo
16492215THONG-STYLE ABSORBENT ARTICLESeptember 2019November 2023Allow5111YesNo
16550390WEARABLE ARTICLE HAVING CHARACTERISTIC MATERIAL PROPERTIESAugust 2019December 2023Allow5220NoNo
16535706PERSONAL HYGIENE PRODUCTAugust 2019August 2023Allow4820NoNo
16531732SYSTEM FOR REGULATING THE DISPENSING OF COMMERCIAL AIRCRAFT PASSENGER OXYGEN SUPPLYAugust 2019August 2023Allow4810NoNo
16482045FLUID-ABSORBENT ARTICLEJuly 2019March 2024Allow5550YesNo
16446118ABSORBENT ARTICLE WITH FUNCTION-FORMED TOPSHEET, AND METHOD FOR MANUFACTURINGJune 2019September 2023Allow5120NoNo
16443766TRANSDERMAL ADMINISTRATION OF MEMANTINEJune 2019November 2023Abandon5310NoNo
16432976DELIVERY OF RESPIRATORY THERAPYJune 2019July 2025Allow6030YesNo
16432264DISPOSABLE ABSORBENT ARTICLE AND A METHOD FOR MAKING THE SAMEJune 2019March 2023Abandon4510NoNo
16412856Disposable Absorbent ArticlesMay 2019March 2023Abandon4610NoNo
16402041HALF FACEPIECEMay 2019January 2023Abandon4401NoNo
16392281CARDED STAPLE FIBER NONWOVENSApril 2019November 2021Allow3100YesNo
16390068NON-INVASIVE BREATHING ASSISTANCE APPARATUS AND METHODApril 2019August 2022Allow4001YesNo
16378640ABSORBENT ARTICLES WITH CHANNELSApril 2019March 2023Abandon4720NoNo
16354906ABSORBENT ARTICLE HAVING A FASTENING SYSTEM WITH A VISUAL CUEMarch 2019April 2022Allow3720YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PHILIPS, BRADLEY H.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
3
(75.0%)
Examiner Reversed
1
(25.0%)
Reversal Percentile
42.0%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
10
Allowed After Appeal Filing
3
(30.0%)
Not Allowed After Appeal Filing
7
(70.0%)
Filing Benefit Percentile
45.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 30.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner PHILIPS, BRADLEY H - Prosecution Strategy Guide

Executive Summary

Examiner PHILIPS, BRADLEY H works in Art Unit 3799 and has examined 127 patent applications in our dataset. With an allowance rate of 70.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 47 months.

Allowance Patterns

Examiner PHILIPS, BRADLEY H's allowance rate of 70.9% places them in the 33% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by PHILIPS, BRADLEY H receive 2.07 office actions before reaching final disposition. This places the examiner in the 54% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by PHILIPS, BRADLEY H is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +22.8% benefit to allowance rate for applications examined by PHILIPS, BRADLEY H. This interview benefit is in the 68% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 26.0% of applications are subsequently allowed. This success rate is in the 42% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 17.6% of cases where such amendments are filed. This entry rate is in the 20% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 24% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 42.9% of appeals filed. This is in the 10% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 27.6% are granted (fully or in part). This grant rate is in the 15% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.2% of allowed cases (in the 69% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.